News

GMP

On March 27, Instituto Latinoamericano de Biotecnología MECHNIKOV received the BPM (Good Manufacturing Practices # nbsp; in English) certification of the manufacturing process of the Fractionated Inactivated Influenza Vaccine indicated for the prevention of influenza. This is an important achievement for the Institute because it consolidates its leadership in the area of ​​the production of Biological products in Central and Latin America.


This new GMP certification allows the MECHNIKOV Institute to expand its offer of services to third parties regarding the production and release of biological products.
This milestone has demonstrated the ability of the MECHNIKOV Institute to certify GMP of the production process, the first of its kind, born from a Technology Transfer project of the Saint Petersburg Vaccine Institute. This has been possible thanks to the close collaboration and trust between the Pan American Health Organization (PAHO), the Ministry of Health of the Republic of Nicaragua, the Center for State Control of Medicines, Equipment and Devices of the Republic of Cuba (CECMED ).
Instituto MECHNIKOV is a # nbsp; pioneer in the production of Biological products # nbsp; in Central America, and is also involved in other technology transfer projects for the treatment and prevention of other pathologies.
Instituto MECHNIKOV has the necessary know-how to deal with manufacturing projects for third parties of biological products.
With this certification, the MECHNIKOV Institute is in a position to comply with international regulations to guarantee the quality, safety and efficacy of the Influenza Vaccine.
2019